Longitudinal study of two cases of progressive multifocal leukoencephalopathy with a clinical benign evolution

References

• Antinori A, Ammassari A, Giancola M L, Cingolani A, Grisetti S, Murri R, Alba L, Ciancio B, Soldani F, Larussa D, Ippolito G, De Luca A. Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era. J NeuroVirol 2001; 7: 323–328
   PubMed Web of Science ®Google Scholar
• Berger J R, Major E O. Progressive multifocal leukoencephalopathy. Semin Neurol 1999; 19: 193–200
   PubMed Web of Science ®Google Scholar
• Bossolasco S, Calori G, Moretti F, Boschini A, Bertelli D, Mena M, Gerevini S, Bestetti A, Pedale R, Sala S, Sala S, Lazzarin A, Cinque P. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy. Clin Infect Dis 2005; 40: 738–744
   PubMed Web of Science ®Google Scholar
• Clerici M, Saresella M, Trabattoni D, Speciale L, Fossati S, Ruzzante S, Cavaretta R, Filippi M, Caputo D, Ferrante P. Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease. J Neuroimmunol 2001; 121: 88–101
   PubMed Web of Science ®Google Scholar
• Clifford D B, Yiannoutsos C, Glicksman M, Simpson D, Singer E J, Piliero P J, Marra C, Francis G S, McArthur J C, Tyler K L, Tselis A C, Hyslop N E. HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 1999; 52: 623–625
   PubMed Web of Science ®Google Scholar
• Delbue S, Pagani E, Guerini F R, Agliardi C, Mancuso R, Borghi E, Rossi F, Boldorini R, Veggiani C, Car P G, Ferrante P. Distribution, characterization and significance of polyomavirus genomic sequences in tumors of the brain and its covering. J Med Virol 2005a; 77: 447–454
   Google Scholar
• Delbue S, Sotgiu G, Fumagalli D, Valli M, Borghi E, Mancuso R, Marchioni E, Maserati R, Ferrante P. A case of a progressive multifocal leukoencephalopathy patient with four different JC virus transcriptional control region rearrangements in cerebrospinal fluid, blood, serum and urine. J NeuroVirol 2005b; 11: 51–57
   PubMed Web of Science ®Google Scholar
• Di Giambenedetto S, Vago G, Pompucci A, Scoppettuolo G, Cingolani A, Marzocchetti A, Tumbarello M, Cauda R, De Luca A. Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity?. Neurology 2004; 63: 2452–2453
   PubMed Web of Science ®Google Scholar
• Du Pasquier R A, Schmitz J E, Jean Jacques J, Zheng Y, Gordon J, Khalili K, Letvin N L, Koralnik I J. Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals. J Virol 2004; 78: 10206–10210
   PubMed Web of Science ®Google Scholar
• Ferrante P, Caldarelli-Stefano R, Omodeo-Zorini E, Vago L, Boldorini R, Costanzi G. PCR detection of JC virus DNA in brain tissue from patients with and without PML. J Med Virol 1995; 47: 219–225
   PubMed Web of Science ®Google Scholar
• Ferrante P, Omodeo-Zorini E, Zuffolato M R, Mancuso R, Caldarelli-Stefano R, Puricelli S, Mediati M, Losciale L, Caputo D. Human T cell lymphotropic virus tax and Epstein Barr virus DNA in peripheral blood of MS patients during acute attack. Acta Neurol Scand Suppl 1997; 169: 79–85
   Google Scholar
• Hoffmann C, Horst H A, Albrecht H, Schlote W. Progressive multifocal leukoencephalopathy with unusual inflammatory response during antiretroviral treatment. J Neurol Neurosurg Psychiatry 2003; 74: 1142–1144
   PubMedGoogle Scholar
• Koralnik I J. New insights into progressive multifocal leukoencephalopathy. Curr Opin Neurol 2004; 17: 365–370
   PubMed Web of Science ®Google Scholar
• Koralnik I J. Progressive multifocal leukoencephalopathy revisited: has the disease outgrown its name?. Ann Neurol 2006; 60: 162–173
   PubMed Web of Science ®Google Scholar
• Lyons A B, Parish C R. Determination of lymphocyte division by flow cytometry. J Immunol Methods 1994; 171: 131–137
   PubMed Web of Science ®Google Scholar
• Marzocchetti A, Di Giambenedetto S, Cingolani A, Ammassari A, Cauda R, De Luca A. Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy. J Clin Microbiol 2005; 43: 4175–4177
   PubMed Web of Science ®Google Scholar
• Mayo H, Collazos J, Martinez E. Progressive multifocal leukoencephalopathy following initiation of highly antiretroviral therapy. AIDS 1998; 12: 1720–1722
   PubMed Web of Science ®Google Scholar
• Safdar A, Rubocki R J, Horvath J A, Narayan K K, Waldron R L. Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution. Clin Infect Dis 2002; 35: 1250–1257
   PubMed Web of Science ®Google Scholar
• Secchiero P, Carrigan D R, Asano Y, Benedetti L, Crowley R W, Komaroff A L, Gallo R C, Lusso P. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis 1995; 171: 273–280
   PubMed Web of Science ®Google Scholar
• Sipe J C, Knobler R L, Braheny S L, Rice G P, Panitch H S, Oldstone M B. A neurologic rating scale (NRS) for use in multiple sclerosis. Neurology 1984; 34: 1368–1372
   PubMed Web of Science ®Google Scholar
• Vendrely A, Bienvenu B, Gasnault J, Thiebault J B, Salmon D, Gray F. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathol (Berl) 2005; 109: 449–455
   PubMed Web of Science ®Google Scholar
• Weber T, Turner R W, Frye S, Ruf B, Haas J, Schielke E, Pohle H D, Luke W, Luer W, Felgenhauer K. Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction. J Infect Dis 1994; 169: 1138–1141
   PubMed Web of Science ®Google Scholar